In the Litigation Daily article by Julie Triedman, "Supreme Court of Canada Rules for GlaxoSmithKline in Transfer-Pricing Case", Claire Kennedy comments on the Supreme Court decision that the Canadian government had to take into account more than just the narrow market price of a product when assessing whether GlaxoSmithKline's transfer pricing was reasonable.
In The News
Claire Kennedy in the Litigation Daily on GlaxoSmithKline Transfer-Pricing Case
December 14, 2012
Republishing Requests
For permission to republish this or any other publication, contact Peter Zvanitajs at ZvanitajsP@bennettjones.com.
For informational purposes only
This publication provides an overview of legal trends and updates for informational purposes only. For personalized legal advice, please contact the authors.
Latest Insights
See All Insights
Blog
Denise D. Bright, Keely Cameron & Chyna Brown
Alberta Court of Appeal Clarifies PPSA Priorities in Insolvency Sales
January 7, 2026
Blog
Katherine Booth & Nina Butz
BC Court of Appeal Dismisses Proposed Privacy Class Action; Finds Use of Professionals' Names Was Not Commercial Exploitation
December 23, 2025Blog
& 1 more
Quantum Computing Investments Aligning with Canada's Defence Priorities
December 23, 2025
Blog
William S. Osler KC, Denise D. Bright & Olu Akinniyi
Alberta Expands ASC Powers to Address Financial Misinformation
December 23, 2025